Propulsid Revised Labeling Reserves Drug For Second-Line Use In GERD

Janssen's Propulsid (cisapride) should be reserved for second-line use, revised labeling recommends following additional reports of cardiac events and deaths associated with the drug for nocturnal heartburn caused by gastroesophageal reflux disease.